Agilon Health (NYSE:AGL) Trading 10.3% Higher – Time to Buy?

Agilon Health, Inc. (NYSE:AGL) shares shot up 10.3% during trading on Monday . The stock traded as high as $89.62 and last traded at $90.18. 226,104 shares traded hands during trading, a decline of 39% from the average session volume of 368,133 shares. The stock had previously closed at $81.73.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and upped their target price for the company from $33.00 to $49.00 in a research report on Thursday, May 7th. Jefferies Financial Group raised Agilon Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $27.50 to $48.00 in a research report on Thursday, May 7th. Robert W. Baird lifted their target price on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price on the stock. in a research report on Monday, May 4th. Finally, Barclays lowered their price target on Agilon Health from $25.00 to $12.50 and set an “underweight” rating on the stock in a research report on Friday, February 27th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Agilon Health presently has a consensus rating of “Hold” and a consensus target price of $45.05.

Agilon Health Trading Up 3.7%

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The company has a market capitalization of $1.41 billion, a price-to-earnings ratio of -3.93 and a beta of 2.29. The firm has a fifty day moving average price of $25.34 and a 200-day moving average price of $20.16.

Agilon Health (NYSE:AGL) last issued its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. As a group, equities analysts anticipate that Agilon Health, Inc. will post -4.17 EPS for the current year.

Hedge Funds Weigh In On Agilon Health

Hedge funds and other institutional investors have recently bought and sold shares of the company. Wealthcare Advisory Partners LLC acquired a new position in Agilon Health in the third quarter valued at approximately $26,000. LPL Financial LLC raised its holdings in shares of Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after purchasing an additional 30,000 shares during the period. Krilogy Financial LLC acquired a new position in shares of Agilon Health during the fourth quarter valued at about $34,000. CIBC Bancorp USA Inc. acquired a new position in shares of Agilon Health during the third quarter worth approximately $34,000. Finally, Merit Financial Group LLC acquired a new position in shares of Agilon Health during the fourth quarter worth approximately $35,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.